Annotation of Allosteric Compounds to Enhance Bioactivity Modeling for Class A GPCRs
暂无分享,去创建一个
Adriaan P IJzerman | Gerard J P van Westen | Chi Chung Lam | Lindsey Burggraaff | Amber van Veen | Herman Van Vlijmen | H. V. van Vlijmen | G. V. van Westen | A. IJzerman | Lindsey Burggraaff | Amber van Veen | C. Lam
[1] Naomi R. Latorraca,et al. Mechanism of intracellular allosteric β2AR antagonist revealed by X-ray crystal structure , 2017, Nature.
[2] E. Novellino,et al. Synthesis, structure-activity relationships and molecular modeling studies of new indole inhibitors of monoamine oxidases A and B. , 2008, Bioorganic & medicinal chemistry.
[3] John P. Overington,et al. ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..
[4] Ruben Abagyan,et al. Structure of CC Chemokine Receptor 2 with Orthosteric and Allosteric Antagonists , 2016, Nature.
[5] Shifan Ma,et al. Prediction of Orthosteric and Allosteric Regulations on Cannabinoid Receptors Using Supervised Machine Learning Classifiers. , 2019, Molecular pharmaceutics.
[6] Shuai Li,et al. ASD v3.0: unraveling allosteric regulation with structural mechanisms and biological networks , 2015, Nucleic Acids Res..
[7] David Rogers,et al. Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..
[8] Gaël Varoquaux,et al. Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..
[9] Patrik Johansson,et al. Structural insight into allosteric modulation of protease-activated receptor 2 , 2017, Nature.
[10] G. Bemis,et al. The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.
[11] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[12] Willem Soudijn,et al. Allosteric modulation of G protein-coupled receptors: perspectives and recent developments. , 2004, Drug discovery today.
[13] Jing Lu,et al. Are there physicochemical differences between allosteric and competitive ligands? , 2017, PLoS Comput. Biol..
[14] Anthony Ivetac,et al. High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875 , 2014, Nature.
[15] Gerard J. P. van Westen,et al. Identification of novel small molecule inhibitors for solute carrier SGLT1 using proteochemometric modeling , 2019, Journal of Cheminformatics.
[16] Bryan L. Roth,et al. Molecular control of δ-opioid receptor signalling , 2014, Nature.
[17] Gerard J. P. van Westen,et al. Chemical, Target, and Bioactive Properties of Allosteric Modulation , 2014, PLoS Comput. Biol..
[18] George Papadatos,et al. The ChEMBL database in 2017 , 2016, Nucleic Acids Res..
[19] Steven M. Moss,et al. Structure of the human P2Y12 receptor in complex with an antithrombotic drug , 2014, Nature.
[20] K. Chung,et al. Orthosteric and allosteric action of the C5a receptor antagonists , 2018, Nature Structural & Molecular Biology.
[21] Gang Fu,et al. PubChem Substance and Compound databases , 2015, Nucleic Acids Res..
[22] Ali Jazayeri,et al. Intracellular allosteric antagonism of the CCR9 receptor , 2016, Nature.
[23] M. Congreve,et al. Applying Structure-Based Drug Design Approaches to Allosteric Modulators of GPCRs. , 2017, Trends in pharmacological sciences.
[24] George Papadatos,et al. The ChEMBL bioactivity database: an update , 2013, Nucleic Acids Res..
[25] M. Liang,et al. Serial millisecond crystallography for routine room-temperature structure determination at synchrotrons , 2017, Nature Communications.
[26] Jens Meiler,et al. Structure of a Class C GPCR Metabotropic Glutamate Receptor 1 Bound to an Allosteric Modulator , 2014, Science.
[27] George Papadatos,et al. Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set , 2017, bioRxiv.
[28] Robert P. Sheridan,et al. Time-Split Cross-Validation as a Method for Estimating the Goodness of Prospective Prediction , 2013, J. Chem. Inf. Model..
[29] Hualiang Jiang,et al. Structure of the CCR5 Chemokine Receptor–HIV Entry Inhibitor Maraviroc Complex , 2013, Science.
[30] Sujata Sharma,et al. Structural basis for the cooperative allosteric activation of the free fatty acid receptor GPR40 , 2017, Nature Structural &Molecular Biology.
[31] Shaoyong Lu,et al. Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions. , 2018, Journal of medicinal chemistry.
[32] R. Sakai,et al. Ligands for ionotropic glutamate receptors. , 2009, Progress in molecular and subcellular biology.